Current Trials
Trial
Urologic Problem
Primary Investigator
Status
InTone: A Revolutionary Device for Home Pelvic Floor Electrical Stimulation and Biofeedback for Urinary Incontinence
Female Urinary Incontinence
Michael Guralnick, MD
Open for enrollment
Safety of Bicalutamide in Chemoprevention of Transitional Cell Carcinoma of the Bladder treated with BCG
Bladder Cancer
William See, MD
EDAP Ablatherm Integrated Imaging High Intensity Focused Ultrasound (HIFU) Indicated for Treatment of Low Risk, Localized Prostate Cancer
Prostate Cancer
Robert Donnell, MD
Closed to enrollment
A Randomized, Double-Blind, Phase 3 Efficacy Trial of PROSTVAC-V/F GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic, Castrate-Resistant Prostate Cancer
Peter Langenstroer, MD
A Randomized Double-Blind Parallel Group Study Comparing Casodex 50mg plus Placebo to Casodex 50mg plus dutasteride 3.5mg Administered for 18 months to Men with Prostate Cancer Who Have Failed First-Line Androgen Deprivation Therapy (Assessed by Rising PSA) Followed by a Two-Year Extension Phase
A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 vs Bicalutamide in Castrate Men with Metastatic Prostate Cancer
Pending IRB approval
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effectiveness of AA4500 Administered Two Times a Week for Up to Three Treatment Cycles (2 x 3) in Subjects With Peyronie’s Disease
Peyronie's
Jon Pryor, MD
Ex Vivo Thermoacoustic Imaging of Prostate Specimens for Cancer Localization
Sarah Patch, PhD
MicroRNA Distribution along Human Nephrons Bank
Renal Cell Cancer
Mingyu Liang, PhD
Future studies:
Past studies:
Please note that our objective is to provide a current list of available clinical trials. A listing does not guarantee that a trial is open to enrollment, and there may be additional trials available that are not listed. Please contact your urologist or the research data coordinator number provided on this web site for complete information.